Results 51 to 60 of about 388,548 (200)
Hepatocellular carcinoma: Review of disease and tumor biomarkers. [PDF]
, 2016 © The Author(s) 2016.Hepatocellular carcinoma (HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative
Cox, IJ +8 more
core +1 more source
International Journal of Infectious Diseases, 2018 Background: The numbers of articles reporting randomized controlled trials (RCTs) on viral hepatitis in China have been increasing, but there have been few systematic studies evaluating the reporting quality of RCTs in this field.
Na Zeng +7 more
doaj +1 more source
NKG2D Enhances Double-Negative T Cell Regulation of B Cells
Frontiers in Immunology, 2021 Numerous studies reported a small subpopulation of TCRαβ+CD4-CD8- (double-negative) T cells that exert regulatory functions in the peripheral lymphocyte population. However, the origin of these double-negative T (DNT) cells is controversial.
Shi-hua Hu +11 more
doaj +1 more source
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]
, 2018 It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P +5 more
core +1 more source
Frontiers in SurgeryBackgroundPyogenic liver abscess caused by migration of an ingested toothpick through occult gastrointestinal perforation is rare and may be missed.Case presentationA 47-year-old woman presented with 2 weeks of fever and epigastric pain. Laboratory tests
Zhigao Yuan +3 more
doaj +1 more source
Survival COVID-19 in Adult Patients with Liver Cirrhosis
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2021 Background: COVID-19 is a disease caused by infection of SARS-CoV-2 virus which leads to mortality due to respiratory failure. The progression of COVID-19 is more severe in patients with pre-existence morbidities, including liver disease. Recently, a few
Gita Aprilicia +9 more
doaj +1 more source
Drug interaction study in hospitalized hepatic cirrhosis patient in Dr.Ramelan navy hospital [PDF]
, 2009 Cirrhotic liver lead to some changes in pathophysiology such as reduction in liver blood flow, decrease some metabolic and synthetic function of the liver. Also there is a change in endothelial lining from hepatic sinusoid.
., Widyati +3 more
core
Ammonia toxicity: from head to toe? [PDF]
, 2016 Ammonia is diffused and transported across all plasma membranes. This entails that hyperammonemia leads to an increase in ammonia in all organs and tissues.
Dasarathy, Srinivasan +6 more
core +1 more source
Hemostatic Abnormalities in Patient with Liver Cirrhosis: A Review
Jurnal Kedokteran Diponegoro, 2022 Liver cirrhosis is one of Indonesia’s most common liver diseases, where the incidence is 38 – 52.8% of all liver diseases. Liver cirrhosis refers to a late-stage pathological lesion caused by the accumulation of extracellular matrix in the liver ...
Wahyuni Wahyuni, Diana Novita
doaj +1 more source
Implantable prosthetic pump boosts blood pressure: A concept [PDF]
, 1975 Prosthetic pump is proposed which can improve liver blood supply by boosting blood pressure locally to the organ.
Fish, J. W.
core +1 more source